about
Advances in the development of biomarkers for epilepsy.Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsyCognitive deficits and brain myo-Inositol are early biomarkers of epileptogenesis in a rat model of epilepsy.Biomarkers of Epileptogenesis: The Focus on Glia and Cognitive Dysfunctions.Inflammation and prevention of epileptogenesis.Inflammation and epilepsy.Immunity activation in brain cells in epilepsy: mechanistic insights and pathological consequences.Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.WONOEP appraisal: Biomarkers of epilepsy-associated comorbidities.Development of In Vivo Imaging Tools for Investigating Astrocyte Activation in Epileptogenesis.In vivo imaging of glia activation using 1H-magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity.Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus.Neuroinflammation imaging markers for epileptogenesis.High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy.Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy.Neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies.The immunoproteasome β5i subunit is a key contributor to ictogenesis in a rat model of chronic epilepsy.Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage.Neuroinflammation Alters Integrative Properties of Rat Hippocampal Pyramidal Cells.A companion to the preclinical common data elements for pharmacologic studies in animal models of seizures and epilepsy. A Report of the TASK3 Pharmacology Working Group of the ILAE/AES Joint Translational Task ForceViral Triggers and Inflammatory Mechanisms in Pediatric EpilepsyInterleukin-1 type 1 receptor/Toll-like receptor signalling in epilepsy: the importance of IL-1beta and high-mobility group box 1Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsyPharmacological targeting of brain inflammation in epilepsy: Therapeutic perspectives from experimental and clinical studiesNeuroinflammatory pathways as treatment targets and biomarkers in epilepsyTLR3 preconditioning induces anti-inflammatory and anti-ictogenic effects in mice mediated by the IRF3/IFN-β axisTargeting oxidative stress improves disease outcomes in a rat model of acquired epilepsyInflammation and reactive oxygen species in status epilepticus: Biomarkers and implications for therapyInflammation and reactive oxygen species as disease modifiers in epilepsy
P50
Q30249613-52086733-CB2B-469A-A469-5EE187CF60D2Q30854108-113B7C77-D1F5-479E-82D3-36E21C939D55Q31095665-4AA30E54-F9B6-45AC-92E6-1F3310BF04F2Q36354351-56668C06-AEBE-463C-9E45-F5C8D7BB0B6FQ37848510-90F8674C-00C9-4DBE-9459-4AAB8F021F4CQ38039590-C074A1E5-28FD-4B4B-9798-02D9E4D4245BQ38156053-A14BED41-AF65-4E5C-B651-4802E4D0BC85Q38748531-2C3EA6D6-4680-481B-B8C8-5915900E7FBDQ38776305-CB4606EF-658C-4DCE-A352-1E855D09B0F2Q40138075-19AFF037-8397-444C-8883-5566DB207B7AQ44258943-B24A2E89-EE38-4C0E-BAE8-142892EB60AAQ44814719-A67AB1FE-C411-4D1A-8284-04C91D985AB9Q46360384-7777CA13-BBB1-40FC-AF6A-22ACC50A812DQ47795739-AEEA5435-AAE8-4831-93E1-C01F7D69DF1BQ47855902-791C2A7B-B5B2-4051-9543-6C808ACEEC0FQ48034056-E0F5E146-F772-4C80-931F-3684C86D1489Q48144612-AE7917C3-095A-497C-9002-7A0450D38832Q48429793-1FC12322-FFF4-4299-964E-311FF2F9BA66Q50090212-1DDF7C18-7BF1-4747-8E61-6E6E65BF071DQ59137534-6E7339FE-3211-4AD2-AE1F-D668356D7D04Q59357537-94B2F1DE-552B-467F-8924-AB6C448F3BE0Q63384072-A897D163-ADA5-40F3-8A74-46294CCD8127Q64067151-8E7022A9-B7AE-4AD0-A1E5-A022A72B892AQ90625637-46BBC26B-5B9E-4A0E-BBB2-F2301ECE49CFQ91530192-3930C11F-23E1-4194-9A66-2EB489BE5754Q92123539-FE9C89DE-A107-4435-B78C-27B307510F4EQ92402028-CA439BB4-38F4-4209-8CED-E8615D1AE1E7Q92570133-BC07FC49-253C-4940-89E6-A62CEE8380E0Q92671093-E32221F0-A1F2-4884-9A53-6D9962BB8A2B
P50
description
investigador
@es
researcher
@en
name
Teresa Ravizza
@en
type
label
Teresa Ravizza
@en
prefLabel
Teresa Ravizza
@en
P31
P496
0000-0002-9578-018X